Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ore Francis

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Infectious Diseases|May 20, 2025
Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) ParticipantsHolly E Baum, Marianna Santopaolo, Ore Francis, et al.
Antibody Therapeutics|December 11, 2023
<i>In vitro</i> generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2Dora Buzas, Adrian H Bunzel, Oskar Staufer, et al.
Communications Medicine|March 16, 2023
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adultsAmy C Thomas, Elizabeth Oliver, Holly E Baum, et al.
Frontiers in Immunology|November 28, 2022
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2Alice Halliday, Anna E Long, Holly E Baum, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Infectious Diseases|May 20, 2025
Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) ParticipantsHolly E Baum, Marianna Santopaolo, Ore Francis, et al.
Antibody Therapeutics|December 11, 2023
<i>In vitro</i> generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2Dora Buzas, Adrian H Bunzel, Oskar Staufer, et al.
Communications Medicine|March 16, 2023
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adultsAmy C Thomas, Elizabeth Oliver, Holly E Baum, et al.
Frontiers in Immunology|November 28, 2022
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2Alice Halliday, Anna E Long, Holly E Baum, et al.
Pageof 2